175 related articles for article (PubMed ID: 28633389)
1. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
[TBL] [Abstract][Full Text] [Related]
2. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.
Perucci LO; Gomes KB; Freitas LG; Godoi LC; Alpoim PN; Pinheiro MB; Miranda AS; Teixeira AL; Dusse LM; Sousa LP
PLoS One; 2014; 9(5):e97632. PubMed ID: 24851923
[TBL] [Abstract][Full Text] [Related]
3. Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
Xu YT; Shen MH; Jin AY; Li H; Zhu R
Int J Gynaecol Obstet; 2017 Jun; 137(3):246-252. PubMed ID: 28281288
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
5. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
[TBL] [Abstract][Full Text] [Related]
6. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of Placental Growth Factor, Transforming Growth Factor-β and Soluble Endoglin in Peripheral Mononuclear Cells in Preeclampsia.
Ali Z; Ali Z; Khaliq S; Zaki S; Ahmad HU; Lone KP
J Coll Physicians Surg Pak; 2019 Mar; 29(3):235-239. PubMed ID: 30823949
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia.
Tobinaga CM; Torloni MR; Gueuvoghlanian-Silva BY; Pendeloski KP; Akita PA; Sass N; Daher S
Acta Obstet Gynecol Scand; 2014 May; 93(5):469-76. PubMed ID: 24580069
[TBL] [Abstract][Full Text] [Related]
9. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
10. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
11. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
12. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.
Rădulescu C; Bacârea A; Huțanu A; Gabor R; Dobreanu M
Mediators Inflamm; 2016; 2016():3027363. PubMed ID: 27799724
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
15. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
16. Altered autophagy induction by sera from pregnant women with pre-eclampsia: a case-control study.
Kanninen TT; Jayaram A; Jaffe Lifshitz S; Witkin SS
BJOG; 2014 Jul; 121(8):958-64. PubMed ID: 24690242
[TBL] [Abstract][Full Text] [Related]
17. Comparison of maternal and umbilical cord blood soluble lectin-like oxidized low-density lipoprotein receptor 1 levels in early- and late-onset preeclampsia.
Tuten A; Erman H; Korkmaz GG; Oncul M; Gelisgen R; Sozer V; Acıkgoz S; Simsek G; Uzun H
Arch Gynecol Obstet; 2014 Nov; 290(5):1007-13. PubMed ID: 24916561
[TBL] [Abstract][Full Text] [Related]
18. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
19. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
Zhang H; Shaw AR; Mak A; Letarte M
J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
[TBL] [Abstract][Full Text] [Related]
20. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]